Laniohan, Joselito B.

HRN: 27-46-89  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/16/2025
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
07/16/2025
07/22/2025
IV
4.5gm
Q8
Cellulitis
Checking Initial Appropriateness 
07/21/2025
CLINDAMYCIN 300MG (CAP)
07/21/2025
07/28/2025
PO
600mg
BID
Cellulitis
Checking Initial Appropriateness 
07/22/2025
CLINDAMYCIN 300MG (CAP)
07/20/2025
07/26/2025
PO
600mg
Q6
Infected Wound
Checking Initial Appropriateness 
07/26/2025
CLINDAMYCIN 150MG/ML, 4ML (AMP)
07/26/2025
08/16/2025
IVT
600mg
Q6
Cellulitis
Checking Initial Appropriateness 
07/28/2025
CEFTRIAXONE 1G (VIAL)
07/28/2025
08/04/2025
IV
2g
OD
Cellulitis
Checking Initial Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: